Breast Cancer Trial, Recruiting NCT07311083 Sponsor: Kliniken Essen-Mitte Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07311083
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 18 and 75 years old
  • You have been diagnosed with triple-negative breast cancer that has not spread to other parts of the body (stage I, II, or III), confirmed by a tissue sample (biopsy)
  • You are planning to receive chemotherapy and immunotherapy before surgery
  • You are willing to take part in the study and have signed a consent form

Who may not be able to join:

  • Your cancer has spread to other parts of the body (metastatic disease)
  • You have a serious physical illness or a psychiatric condition requiring medication that would prevent you from taking part
  • You are pregnant
  • You are already taking part in another clinical study involving behavioural, psychological, or complementary health treatments
  • You follow a diet that does not work alongside a high-fibre diet, such as a ketogenic (very low-carb) diet
  • You have a problem with drug or alcohol misuse
  • You are unable to fill in questionnaires on your own
  • You have had your colon (large bowel) surgically removed
  • You have a narrowing in your digestive tract (confirm with trial site)
  • You have an intolerance to fructose (a type of sugar found in fruit and some foods)
  • You have a histamine intolerance (a sensitivity to histamine found in certain foods)
  • You have a gluten intolerance or coeliac disease
  • You are currently following a ketogenic diet
  • You are unwilling to stop taking probiotic supplements for the length of the study
  • You have or have had an eating disorder
  • You do not have access to a laptop and/or a camera to join the online group sessions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kliniken Essen-Mitte
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
1 July 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

The primary target parameter is the feasibility of the planned study and the intervention.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov